Regulation & law · 08/04/2019Updated: 10/17/2026 · 1 min read

DEA Proposes Scheduling of 6 Synthetic Cannabinoids, Including 5F-ADB and MDMB-FUBINACA

The Drug Enforcement Administration (DEA) has proposed placing six synthetic cannabinoids, including 5F-ADB and MDMB-FUBINACA, in Schedule I of the Controlled Substances Act, which would make permanent existing regulatory controls and sanctions for handling these substances.